Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial Meeting Abstract
| Authors: | Carvajal, R. D.; Agulnik, M.; Ryan, C. W.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H. A. H.; Elias, A. D.; Read, W. L.; Budd, G. T.; Hirman, J.; Weiden, P.; Bennett, C. M.; Livingston, P. O.; Hansen, D.; Maki, R. G.; Schwartz, G. K.; Chugh, R. |
| Abstract Title: | Trivalent ganglioside vaccine and immunologic adjuvant versus adjuvant alone in metastatic sarcoma patients rendered disease-free by surgery: A randomized phase 2 trial |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204653 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.10520 |
| Notes: | Meeting Abstract: 10520 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
385Schwartz -
148Carvajal -
241Maki -
228Livingston
Related MSK Work